Phase 1 Single and Multiple Ascending Dose of LTG-321 in Healthy Participants

Clinical trial NCT07110610 · COMPLETED

Trial details

NCT number: NCT07110610
Sponsor: Latigo Biotherapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Participants

Start date: 2025-09-03
Primary completion: 2026-03-08
Enrollment: 112

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.